| Literature DB >> 26140606 |
Daniel Hiler1, Xiang Chen2, Jennifer Hazen3, Sergey Kupriyanov4, Patrick A Carroll5, Chunxu Qu2, Beisi Xu2, Dianna Johnson6, Lyra Griffiths1, Sharon Frase7, Alberto R Rodriguez4, Greg Martin4, Jiakun Zhang1, Jongrye Jeon1, Yiping Fan2, David Finkelstein2, Robert N Eisenman5, Kristin Baldwin3, Michael A Dyer8.
Abstract
Cell-based therapies to treat retinal degeneration are now being tested in clinical trials. However, it is not known whether the source of stem cells is important for the production of differentiated cells suitable for transplantation. To test this, we generated induced pluripotent stem cells (iPSCs) from murine rod photoreceptors (r-iPSCs) and scored their ability to make retinae by using a standardized quantitative protocol called STEM-RET. We discovered that r-iPSCs more efficiently produced differentiated retinae than did embryonic stem cells (ESCs) or fibroblast-derived iPSCs (f-iPSCs). Retinae derived from f-iPSCs had fewer amacrine cells and other inner nuclear layer cells. Integrated epigenetic analysis showed that DNA methylation contributes to the defects in f-iPSC retinogenesis and that rod-specific CTCF insulator protein-binding sites may promote r-iPSC retinogenesis. Together, our data suggest that the source of stem cells is important for producing retinal neurons in three-dimensional (3D) organ cultures.Entities:
Mesh:
Year: 2015 PMID: 26140606 PMCID: PMC4547539 DOI: 10.1016/j.stem.2015.05.015
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633